PF-Atlas › Clinical Trials › NCT06097260

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast for Idiopathic Pulmonary Fibrosis

PLN-74809 · Phase 2

Registry ID
NCT06097260
Phase
Phase 2
Status
Terminated
Drug / intervention
PLN-74809
Sponsor
Pliant Therapeutics, Inc.
Start
2023-11-16

About this trial

PLN-74809 is evaluated in NCT06097260, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Pliant Therapeutics, Inc.. Current status: Terminated.

View NCT06097260 on ClinicalTrials.gov →

Explore related

PLN-74809 — Treatment profileAll PLN-74809 trialsAll IPF trials

Related trials

PLN-74809 — INTEGRIS-IPFPLN-74809 — NCT04072315PLN-74809 — NCT04396756
Medical disclaimer. This page summarizes public trial data for NCT06097260 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.